KRN-7000(S34)
DC67239
View product →
α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor).
| CAS No. | 158021-47-7 |
| Chemical Name | α-Galactosylceramide |
| Synonyms | Hexacosanamide,N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;α-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;alpha-Galactosylceramide;KRN 7000;N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide;α-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;α1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine;AGL-582;Α-GALACTOSYL CERAMIDE;α-GalCer;(2S,3S,4R)-1-O-(α-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;N-[(1S,2S,3R)-1-[(α-D-Galactopyranosyloxy)Methyl]-2,3-dihydroxyheptadecyl]hexacosanaMide;KRN7000;α-Galactosyl CeraMide;α-Galactosylceramide;A-Galactosylceramide;AKOS040741093;HEXACOSANAMIDE, N-((1S,2S,3R)-1-((.ALPHA.-D-GALACTOPYRANOSYLOXY)METHYL)-2,3-DIHYDROXYHEPTADECYL)-;EX-A5755;N-((2S,3S,4R)-3,4-dihydroxy-1-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadecan-2-yl)hexacosanamide;Krn-7000;hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;SCHEMBL512949;CHEBI:466659;N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE;RGI-7000;-GalCer;KRN7000;(2S,3S,4R)-1-O-(alpha-D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;.alpha.-galcer;C16892;-Galactosylceramide;alpha-GalCer(t18:0/26:0);Hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9CI);Krn 7000;N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide;AC-31508;Q27105159;CHEMID158021477;GLXC-26234;Epitope ID:130694;RGI-2001;N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide;Galalpha-Cer(t18:0/26:0);UNII-WX671898JF;WX671898JF;A-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;alpha-Galactosylceramide(a-Gal-Cer) (synthetic);1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine;Hexacosanamide, N-[1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-;CCRIS 8968;(2S,3S,4R)-1-O-(alpha-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (TLC);alpha-GalCer;CHEMBL384200;Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-;NS00073040;alpha-Galactosyl Ceramide;alpha-GC(C26);DTXSID40935847;MFCD00939559;VQFKFAKEUMHBLV-BYSUZVQFSA-N;??-Galactosylceramide;DB12232;158021-47-7;N-((2S,3S,4R)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide;alpha-GC (C26);(+)-KRN-7000 |
| SMILES | CCCCCCCCCCCCCCCCCCCCCCCCCC(N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)=O |
| Formula | C50H99NO9 |
| M.Wt | 858.32236 |
| Purity | >98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Not available |
| Product classification | Adjuvant Molecules |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.6506 mL | 2.3301 mL | 1.1651 mL |
| 25 mg | 29.1266 mL | 5.8253 mL | 2.9127 mL |
| 50 mg | 58.2532 mL | 11.6506 mL | 5.8253 mL |
| 100 mg | 116.5063 mL | 23.3013 mL | 11.6506 mL |
| 250 mg | 291.2659 mL | 58.2532 mL | 29.1266 mL |
Contact our team with the catalog number and requested quantity.